Knieps; Stephanie Patent Filings

Patent	Date
2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes Grant 7,956,077 - Glombik , et al. June 7, 2	2011-06-07
Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes Grant 7,598,281 - Glombik , et al. October 6, 2	2009-10-06
2-{-3-'2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes Grant 7,538,131 - Glombik , et al. May 26, 2	2009-05-26
2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl Methoxy}-propionic Acid Derivatives Used As Peroxisome Proliferator-activated Receptor (ppar) Ligands For The Treatment Of Hyperlipidemia And Diabetes App 20070197613 - Glombik; Heiner ; et al.	2007-08-23
Arylcycloakyl-substituted Alkanoic Acid Derivatives Useful As Peroxisome Proliferator-activated Receptor (ppar) Ligands For The Treatment Of Hyperlipidemia And Diabetes App 20070197605 - Glombik; Heiner ; et al.	2007-08-23
2-{-3-'2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic Acid Derivatives Useful As Peroxisome Proliferator-activated Receptor (ppar) Ligands For The Treatment Of Hyperlipidemia And Diabetes App 20070197612 - Glombik; Heiner ; et al.	2007-08-23

Patent

Date

2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes
Grant 7,956,077 - Glombik , et al. June 7, 2

2011-06-07

Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes
Grant 7,598,281 - Glombik , et al. October 6, 2

2009-10-06

2-{-3-'2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes
Grant 7,538,131 - Glombik , et al. May 26, 2

2009-05-26

2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl Methoxy}-propionic Acid Derivatives Used As Peroxisome Proliferator-activated Receptor (ppar) Ligands For The Treatment Of Hyperlipidemia And Diabetes
App 20070197613 - Glombik; Heiner ; et al.

2007-08-23

Arylcycloakyl-substituted Alkanoic Acid Derivatives Useful As Peroxisome Proliferator-activated Receptor (ppar) Ligands For The Treatment Of Hyperlipidemia And Diabetes
App 20070197605 - Glombik; Heiner ; et al.

2007-08-23

2-{-3-'2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic Acid Derivatives Useful As Peroxisome Proliferator-activated Receptor (ppar) Ligands For The Treatment Of Hyperlipidemia And Diabetes
App 20070197612 - Glombik; Heiner ; et al.

2007-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Knieps; Stephanie

Patent Applications and Registrations